Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
IMNM
#1681
Immunome, Inc.
21.8
6
+1.30%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+1.30%
Variazione Mensile
-14.81%
Variazione di 6 mesi
+119.26%
Variazione Annuale
+151.55%
Chiusura Precedente
21.5
8
Open
21.8
6
Bid
Ask
Low
21.8
6
High
21.8
6
Volume
116
Mercati
Mercato Azionario Statunitense
Salute
IMNM
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
10.66 M
12.13 M
12.22 M
59.69 M
86.95 M
—
Valuation ratios
Enterprise value
63.42 M
107.94 M
19.5 M
558.55 M
780.02 M
2.57 B
Price to earnings ratio
—
-6.06
-1.06
-2.05
-2.12
-11.77
Price to sales ratio
—
14.95 K
7 906.53
13.05
28.46
114.42
Price to cash flow ratio
—
8.2
1.38
28.87
5.62
17.03
Price to book ratio
—
3.1
2.37
1.82
3.44
5.47
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.4
0.43
1.53
0.72
1.22
0.79
Return on equity %
0.43
0.51
2.22
0.89
1.62
0.96
Return on invested capital %
2 229.27
2 415.33
3 126.87
4 185.73
3 469.78
—
Gross margin %
100
100
100
100
100
400
Operating margin %
32.27 K
252.04 K
738.02 K
654.22
1 397.75
5 171.71
EBITDA margin %
—
—
—
—
—
—
Net margin %
46.84 K
247 K
738 K
637.92
1 339.08
4 927.86
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
14.12
5.82
3.09
6.63
4.08
35.6
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0.19
0.11
0.07
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
—
—
—
—
Long term debt to total equity ratio
0
0
—
—
—
—
Per share metrics
Operating cash flow per share
—
1.58
2.37
0.38
1.89
2.41
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
4.27
1.68
6.96
3.71
13.88
Net current asset value per share
—
4.91
1.87
7.29
3.77
14.21
Tangible book value per share
—
4.18
1.37
6.04
3.09
13.05
Working capital per share
—
4.07
1.26
6.19
2.85
12.28
Book value per share
—
4.18
1.37
6.04
3.09
13.05
Notizie
H.C. Wainwright avvia copertura su Immunome con rating Buy
Immunome stock hits 52-week high at $26.74
Il titolo di Immunome raggiunge il massimo di 52 settimane a $25,32
Immunome stock reaches 52-week high at $25.32
Il CEO di Immunome (IMNM) Siegall acquista azioni per 100.000 dollari
Immunome (IMNM) CEO Siegall buys $100k in shares
Guggenheim conferma il rating Buy sulle azioni Immunome dopo finanziamento di $400M
Guggenheim reiterates Buy rating on Immunome stock following $400M financing
Siegall acquista azioni Immunome (IMNM) per 149.000 dollari
Philip Tsai acquista azioni Immunome per 204.899 dollari
Tsai Philip buys $204,899 in Immunome stock
Immunome: Maintaining "Strong Buy" On Successful RINGSIDE Trial With Varegacestat (IMNM)